tetano
Editor, Senior Moderator
Pulm Circ
. 2020 May 18;10(2):2045894020924566.
doi: 10.1177/2045894020924566. eCollection Apr-Jun 2020.
Understanding the Current Status of Patients With Pulmonary Hypertension During COVID-19 Outbreak: A Small-Scale National Survey From China
Hongmei Zhou[SUP] 1 [/SUP], Gangcheng Zhang[SUP] 1 [/SUP], Xiaoxian Deng[SUP] 1 [/SUP], Bowen Jin[SUP] 1 [/SUP], Qiu Qiu[SUP] 1 [/SUP], Menghuan Yan[SUP] 1 [/SUP], Xi Wang[SUP] 1 [/SUP], Xuan Zheng[SUP] 1 2 [/SUP]
Affiliations
Abstract
Pulmonary hypertension is a chronic disease developing progressively with high mortality. Pulmonary hypertension patients need persistent medical care; however, limited reports focused on them when there was an outbreak of coronavirus disease 2019 in China. This national survey was aimed to evaluate the overall condition of pulmonary hypertension patients during this period. A questionnaire regarding the living condition of pulmonary hypertension patients during coronavirus disease 2019 was designed by pulmonary hypertension diagnostic experts in Wuhan Asia Heart Hospital. Pulmonary hypertension patients and their family members were invited to participate in this survey online. One-hundred twenty pulmonary hypertension patients and 23 family members participated in the survey; 64.8% (n = 87) participants came from Hubei, and others were from 15 other provinces; 98.6% (n = 141) participants were in home quarantine; 65.8% (n = 79) were pulmonary arterial hypertension associated with congenital heart disease; and 76.7% (n = 92) patients proclaimed their heart function was well maintained at class I or II. One (0.8%) patient was confirmed severe acute respiratory syndrome coronavirus 2 infection. Two (1.7%) patients were hospitalized due to heart function worsening. Nearly 70% (n = 100) participants implied shortage in medications during coronavirus disease 2019 outbreak. A total of 24.2% (n = 29) patients indicated that medications were discontinued due to the insufficient supply. Most of the participants stayed optimistic on either coronavirus disease 2019 outbreak or their pulmonary hypertension disease, and 61.7% (n = 74) patients would go to the hospital for follow-up immediately after outbreak. These preliminary data show pulmonary hypertension patients are able to avoid severe disease when they are in home quarantine. Medication supplement is important for pulmonary hypertension patients when their heart function is well maintained. In addition, there might be increasing requirements of medical care for pulmonary hypertension patients after the outbreak.
Keywords: coronavirus disease 2019 (COVID-19); medical care; pulmonary hypertension.
. 2020 May 18;10(2):2045894020924566.
doi: 10.1177/2045894020924566. eCollection Apr-Jun 2020.
Understanding the Current Status of Patients With Pulmonary Hypertension During COVID-19 Outbreak: A Small-Scale National Survey From China
Hongmei Zhou[SUP] 1 [/SUP], Gangcheng Zhang[SUP] 1 [/SUP], Xiaoxian Deng[SUP] 1 [/SUP], Bowen Jin[SUP] 1 [/SUP], Qiu Qiu[SUP] 1 [/SUP], Menghuan Yan[SUP] 1 [/SUP], Xi Wang[SUP] 1 [/SUP], Xuan Zheng[SUP] 1 2 [/SUP]
Affiliations
- PMID: 32523686
- PMCID: PMC7235682
- DOI: 10.1177/2045894020924566
Abstract
Pulmonary hypertension is a chronic disease developing progressively with high mortality. Pulmonary hypertension patients need persistent medical care; however, limited reports focused on them when there was an outbreak of coronavirus disease 2019 in China. This national survey was aimed to evaluate the overall condition of pulmonary hypertension patients during this period. A questionnaire regarding the living condition of pulmonary hypertension patients during coronavirus disease 2019 was designed by pulmonary hypertension diagnostic experts in Wuhan Asia Heart Hospital. Pulmonary hypertension patients and their family members were invited to participate in this survey online. One-hundred twenty pulmonary hypertension patients and 23 family members participated in the survey; 64.8% (n = 87) participants came from Hubei, and others were from 15 other provinces; 98.6% (n = 141) participants were in home quarantine; 65.8% (n = 79) were pulmonary arterial hypertension associated with congenital heart disease; and 76.7% (n = 92) patients proclaimed their heart function was well maintained at class I or II. One (0.8%) patient was confirmed severe acute respiratory syndrome coronavirus 2 infection. Two (1.7%) patients were hospitalized due to heart function worsening. Nearly 70% (n = 100) participants implied shortage in medications during coronavirus disease 2019 outbreak. A total of 24.2% (n = 29) patients indicated that medications were discontinued due to the insufficient supply. Most of the participants stayed optimistic on either coronavirus disease 2019 outbreak or their pulmonary hypertension disease, and 61.7% (n = 74) patients would go to the hospital for follow-up immediately after outbreak. These preliminary data show pulmonary hypertension patients are able to avoid severe disease when they are in home quarantine. Medication supplement is important for pulmonary hypertension patients when their heart function is well maintained. In addition, there might be increasing requirements of medical care for pulmonary hypertension patients after the outbreak.
Keywords: coronavirus disease 2019 (COVID-19); medical care; pulmonary hypertension.